AXQ Capital LP Invests $206,000 in Maximus, Inc. (NYSE:MMS)

AXQ Capital LP acquired a new stake in Maximus, Inc. (NYSE:MMS) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 2,764 shares of the health services provider’s stock, valued at approximately $206,000.

Other large investors have also recently added to or reduced their stakes in the company. UMB Bank n.a. grew its position in shares of Maximus by 79.8% in the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock valued at $27,000 after purchasing an additional 158 shares during the last quarter. Eastern Bank purchased a new stake in Maximus in the 4th quarter valued at approximately $29,000. V Square Quantitative Management LLC grew its holdings in Maximus by 65.9% during the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock valued at $34,000 after buying an additional 180 shares during the last quarter. R Squared Ltd purchased a new position in Maximus during the fourth quarter worth $54,000. Finally, IFP Advisors Inc raised its holdings in shares of Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock worth $59,000 after acquiring an additional 302 shares during the last quarter. 97.21% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts recently commented on MMS shares. Raymond James upgraded Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective for the company in a research report on Thursday, January 2nd. StockNews.com downgraded shares of Maximus from a “buy” rating to a “hold” rating in a report on Friday, February 14th.

Insider Activity

In other news, Director Jan Madsen sold 2,439 shares of the company’s stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the transaction, the director now directly owns 18,097 shares in the company, valued at approximately $1,225,347.87. This represents a 11.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Ilene R. Baylinson sold 14,500 shares of the firm’s stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the sale, the insider now directly owns 2,512 shares of the company’s stock, valued at approximately $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

Maximus Price Performance

Maximus stock opened at $66.48 on Tuesday. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. The company has a market cap of $3.76 billion, a price-to-earnings ratio of 14.30 and a beta of 0.71. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.97. The firm has a 50 day moving average price of $70.86 and a 200 day moving average price of $78.31.

Maximus (NYSE:MMS) last announced its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Sell-side analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Saturday, February 15th were given a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.80%. The ex-dividend date was Friday, February 14th. Maximus’s payout ratio is 25.81%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.